In the pipeline, we have an ideal agent, Collagenderm*, for soft-tissue augmentation for use in a variety of facial cosmetic and reconstructive treatments.

We have also developed an injectable allogenic human tissue matrix, Collagenuro*, for treatment of stress incontinence or urinary incontinence subsequent to radical retropubic prostatectomy or TUP-P.

A new graft implant, Surgerepair*, for reinforcement of soft tissue is one of our newer products subject to ongoing preclinical studies.

*Proprietary names for ELIXIGEN